James R. Beasley

James R. Beasley is a seasoned professional in drug discovery and development, currently serving as Managing Director at Genesis Drug Discovery & Development since April 2022. Previously, James held the position of Director of Discovery Biology at Venenum BioDesign, focusing on early-phase drug research in metabolic disorders, women's health, and oncology. James also contributed as a Senior Research Investigator at Ligand Pharmaceuticals, managing collaborations and budgets, and as a Senior Principal Scientist at Pharmacopeia, overseeing research plans for assay development and high-throughput screening. Earlier career experience includes a Senior Scientist role at DGI Biotechnologies, where James advanced high-throughput screening technologies. Academically, James holds a Ph.D. in Biochemistry from the University of North Carolina at Chapel Hill and completed postdoctoral studies at Princeton University, following a B.S. in Chemistry from The University of Texas at Austin.